Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs
- PMID: 11449879
- DOI: 10.1093/ajhp/58.13.1218
Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs
Abstract
The stability and compatibility of tirofiban hydrochloride injection during simulated Y-site administration with various other drugs were studied. Tirofiban hydrochloride, dobutamine, epinephrine hydrochloride, furosemide, midazolam hydrochloride, and propranolol hydrochloride injections were each prepared from their respective concentrates in both 0.9% sodium chloride injection and 5% dextrose injection at both the minimum and maximum concentrations normally administered. The high-concentration solutions of midazolam hydrochloride and furosemide were used as is. Morphine sulfate was diluted in 5% dextrose injection only. Nitroglycerin premixed infusions, atropine sulfate injection, and diazepam injection were used as is. Tirofiban hydrochloride solutions were combined 1:1 with each of the secondary drug solutions in separate glass containers. Samples were stored for four hours at room temperature under ambient fluorescent light and were assayed for drug content and degradation by high-performance liquid chromatography and for pH, appearance, and turbidity. All mixtures except those containing diazepam remained clear and colorless, with no visual or turbidimetric indication of physical instability. Mixing of tirofiban hydrochloride and diazepam solutions resulted in immediate precipitation. all remaining mixtures remained clear. There was no significant loss of any of the drugs tested, no increase in known degradation products, and no appearance of unknown drug-related peaks. The pH of all test solutions remained constant. Tirofiban hydrochloride injection 0.05 mg/mL was stable for at least four hours when combined 1:1 in glass containers with atropine sulfate, dobutamine, epinephrine hydrochloride, furosemide, midazolam hydrochloride, morphine sulfate, nitroglycerin, and propranolol hydrochloride at the concentrations studied. Tirofiban hydrochloride was incompatible with diazepam.
Similar articles
-
Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration.J Clin Pharm Ther. 1999 Apr;24(2):125-32. doi: 10.1046/j.1365-2710.1999.00208.x. J Clin Pharm Ther. 1999. PMID: 10380064
-
Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.Am J Health Syst Pharm. 2008 Sep 15;65(18):1735-59. doi: 10.2146/ajhp070293. Am J Health Syst Pharm. 2008. PMID: 18769000
-
Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration.Am J Health Syst Pharm. 2005 Jul 1;62(13):1381-4. doi: 10.2146/ajhp040391. Am J Health Syst Pharm. 2005. PMID: 15972381
-
Stability of milrinone and digoxin, furosemide, procainamide hydrochloride, propranolol hydrochloride, quinidine gluconate, or verapamil hydrochloride in 5% dextrose injection.Am J Hosp Pharm. 1988 Oct;45(10):2079-91. Am J Hosp Pharm. 1988. PMID: 3228079
-
Stability and compatibility of morphine.Int J Pharm. 1999 Sep 30;187(1):17-51. doi: 10.1016/s0378-5173(99)00181-7. Int J Pharm. 1999. PMID: 10502612 Review.
Cited by
-
Supersaturated state of diazepam injection following dilution with infusion fluid.J Pharm Health Care Sci. 2015 Mar 9;1:9. doi: 10.1186/s40780-014-0009-9. eCollection 2015. J Pharm Health Care Sci. 2015. PMID: 26819720 Free PMC article.
-
Chitosan as possible inhibitory agents and delivery systems in leukemia.Cancer Cell Int. 2021 Oct 18;21(1):544. doi: 10.1186/s12935-021-02243-w. Cancer Cell Int. 2021. PMID: 34663339 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical